OrthoPediatrics Up Over 10%, on Track for Largest Percent Increase Since March 2025 -- Data Talk

Dow Jones
Feb 28

OrthoPediatrics Corp. $(KIDS)$ is currently at $19.65, up $1.86 or 10.46%

 

--Would be highest close since Jan. 12, 2026, when it closed at $20.11

--On pace for largest percent increase since March 5, 2025, when it rose 11.88%

--Currently up three consecutive days; up 22.2% over this period

--Best three day stretch on record (Based on available data back to Oct. 12, 2017)

--Up 15.86% this week; best weekly performance since the week ending Aug. 23, 2024, when it rose 19.01%

--Up 12.54% month-to-date; on pace for best month since Nov. 2023, when it rose 26.04%

--Up 10.64% year-to-date

--Down 73.06% from its all-time closing high of $72.93 on Nov. 5, 2021

--Down 15.37% from 52 weeks ago (Feb. 28, 2025), when it closed at $23.22

--Down 25.31% from its 52-week closing high of $26.31 on April 2, 2025

--Up 22.2% from its 52-week closing low of $16.08 on Feb. 24, 2026

--Traded as high as $20.20; highest intraday level since Jan. 13, 2026, when it hit $20.34

--Up 13.55% at today's intraday high; largest intraday percent increase since Nov. 14, 2023, when it rose as much as 14.81%

 

All data as of 2:02:26 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

February 27, 2026 14:05 ET (19:05 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10